Some transcription factors can regulate ferroptosis through the system Xc-/GSH/GPX4 pathway
One possible explanation is your body adjusting to B12 replenishment
Dihexa (chemical name N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, development code PNB-0408) is a synthetic peptide derived from angiotensin IV, originally developed by researchers at Washington State University as a potential therapy for Alzheimer's disease
NAD+ levels decline measurably with age, with stress, and with illness
Key characteristics relevant to researchers: Defined molecular formula and weight, verifiable via COA A single active moiety, making structure-activity and stability studies more straightforward to interpret A relatively simple synthesis pathway compared to longer peptides, given its short tripeptide backbone What a "Blend" Product Is A blend, such as our Glow Blend listing, refers to a formulated combination of multiple peptide compounds supplied together rather than as isolated single compounds
Higher doses may result in faster hunger reduction, but they should always be prescribed and monitored by a healthcare provider
